Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | CA4 | P22748 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL28907546 | 0.97 | TP53 (0.65) | TP53CA4TSHRSLC7A5CA2 | |
| Lactic Acid SCHEMBL27708305 | 0.94 | TP53 (0.61) | TP53CA4TSHRCA1 | |
| Lactic Acid SCHEMBL8677110 | 0.94 | TP53 (0.69) | TP53CA4TSHRSLC7A5CA1 | |
| Lactic Acid SCHEMBL27356549 | 0.94 | TP53 (0.69) | TP53CA4TSHRSLC7A5CA1 | |
| Lactic Acid SCHEMBL264447 | 0.94 | TP53 (0.69) | TP53CA4TSHRCA1CA2 | |
| Lactic Acid SCHEMBL15544221 | 0.94 | TP53 (0.69) | TP53CA4TSHRCA1CA2 | |
| Lactic Acid SCHEMBL8024518 | 0.94 | TP53 (0.69) | TP53CA4TSHRCA1CA2 | |
| Lactic Acid SCHEMBL29738158 | 0.94 | TP53 (0.69) | TP53CA4TSHRSLC7A5CA1 | |
| Lactic Acid SCHEMBL10320997 | 0.91 | TP53 (0.65) | TP53CA4TSHRCA1CA2 | |
| Lactic Acid SCHEMBL10751024 | 0.91 | TP53 (0.65) | TP53CA4TSHRSLC7A5CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114246953-B | Anti-cMet antibody drug conjugates and methods of use thereof | 艾伯维生物制药股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| US-20210171573-A1 | IMPROVED PROTEIN RECOVERY | BRISTOL-MYERS SQUIBB COMPANY | 2021-06-10 | — | — | US | claimed |
| CN-112566920-A | Improved protein recovery | 百时美施贵宝公司 | 2021-03-26 | — | — | CN | claimed |
| CN-105399622-B | A kind of method of use heavy constituent production of lactic acid potassium lactate | 武汉三江航天固德生物科技有限公司 | 2017-09-19 | — | — | CN | claimed |
| CN-106074620-A | Active probiotic application, suspension and probiotic bacteria non-woven fabrics in nursing materials | 云南白药清逸堂实业有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-105997840-A | Application of inactivated probiotics in care products, suspension and probiotic nonwoven fabric | 云南白药清逸堂实业有限公司 | 2016-10-12 | — | — | CN | claimed |
| US-7053166-B2 | Preparation of organically modified polyorganosiloxanes | GOLDSCHMIDT GMBH (DE) | 2006-05-30 | — | — | US | claimed |
| US-20040186259-A1 | Preparation of organically modified polyorganosiloxanes | EVONIK GOLDSCHMIDT GMBH (DE) | 2004-09-23 | — | — | US | claimed |
| EP-4739300-A1 | MODULATORS OF IRON METABOLISM FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739297-A1 | MODULATORS OF LYPOXYGENASES FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739298-A1 | ACTIVATORS OF THE XC- SYSTEM AND/OR GPX-4 FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4519316-A1 | NEW FORMULATION OF ANTI VISTA ANTIBODY | PIERRE FABRE MEDICAMENT (FR) | 2025-03-12 | — | — | EP | disclosed |
| EP-4511378-A1 | SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS | Carthronix, Inc. (US) | 2025-02-26 | — | — | EP | disclosed |
| WO-2025012668-A1 | MODULATORS OF IRON METABOLISM FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2025-01-16 | — | — | WO | disclosed |
| EP-0284249-A1 | Lyophilized lymphokine composition | INTERFERON SCIENCES, INC. (US) | 1988-09-28 | — | — | EP | disclosed |
| US-4675184-A | VIRICIDES | 501 Sunstar Kabushiki Kaisha (JP) | 1987-06-23 | — | — | US | disclosed |
| EP-0080879-B1 | PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON IN STABLE STATE | SUNSTAR KABUSHIKI KAISHA (JP) | 1986-10-01 | — | — | EP | disclosed |
| US-4605555-A | INTERFERON, POLYHYDRIC SUGAR ALCOHOL, ORGANIC ACID BUFFER | SUN STAR KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | disclosed |
| US-4605556-A | APPLYING INTERFERON, POLYHYDRIC SUGAR ALCOHOL, AND ORGANIC ACID BUFFER | SUN STAR KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | disclosed |
| EP-0080879-A2 | Pharmaceutical composition containing interferon in stable state | SUNSTAR KABUSHIKI KAISHA (JP) | 1983-06-08 | — | — | EP | disclosed |